The expression of nicotinic acetylcholine receptor subunits and their associations with local immune cells and prognosis in oral squamous cell carcinoma
Cancer Medicine · 2023
DOI: 10.1002/cam4.6482 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Chi-Maw Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, National Taiwan University Hospital, Yun-Lin Branch, Taipei, Taiwan. Hauptthemen laut MEDLINE: Receptors, Nicotinic, Carcinoma, Squamous Cell, Mouth Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Taiwan University Hospital.
Abstract (Originalsprache)
Background
Nicotinic acetylcholine receptors (nAChRs) are ligand‐gated ion channels that may be responsible for cancer cell proliferation, epithelial–mesenchymal transition (EMT), and immune regulation. However, little is known about the associations of different nAChR subunits with tumor microenvironment in oral squamous cell carcinoma (OSCC).
Methods
We retrospectively reviewed pathology samples from 75 OSCC patients by immunohistochemistry. In addition, a cohort of 307 OSCC patients in The Cancer Genome Atlas was analyzed.
Results
Subunit α1 was specific to peri‐OSCC skeletal muscle. Increased α1 was associated with increased CD44 (cancer stem cells), increased CD3 and 8 (T cells), increased CD56 and 16 (natural killer cells), a decreased T stage, and an increased N stage. Increased α3 was associated with increased CD56 and 16. Increased α5 was associated with decreased CD3, 8, and 56, a decreased T stage, an increased N stage, worse survival, and decreased epithelial features. Increased α7 was associated with increased CD3, 8, 56, and 16, decreased tumor/peritumor ratios of CD3, 8, and 56 immune cells, and increased epithelial features. Increased local immune cells were associated with a better prognosis. Conclusions α5 is the only subunit associated with decreased local immune cells and worse survival, while α1, α3, and α7 are associated with increased local immune cells in OSCC. α5 and α7 are correlated with different EMT states to be mesenchymal‐like and epithelial‐like OSCC, respectively. Protein expression data of the nAChR subunits, complementary to gene expression data, could provide meaningful information regarding the EMT status of OSCC associated with immune responses and prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, National Taiwan University Hospital, Yun-Lin Branch, Taipei, Taiwan.
- Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Department of Pathology, National Taiwan University Hospital, Yun-Lin Branch, Taipei, Taiwan.
- Department of Otolaryngology, National Taiwan University Hospital and National Taiwan University, College of Medicine, Taipei, Taiwan.
- Department of Biotechnology, National Formosa University, Huwei, Taiwan.
ORCID-Profile: Chi-Maw Lin
Förderung
- National Taiwan University Hospital
Zitieren
APA
Lin, C. M., Lin, L. W., Chen, T. C., Ye, Y. L., & Chiang, B. L. (2023). The expression of nicotinic acetylcholine receptor subunits and their associations with local immune cells and prognosis in oral squamous cell carcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.6482
Vancouver
Lin CM, Lin LW, Chen TC, Ye YL, Chiang BL. The expression of nicotinic acetylcholine receptor subunits and their associations with local immune cells and prognosis in oral squamous cell carcinoma. Cancer Medicine. 2023. doi:10.1002/cam4.6482
BibTeX
@article{Lin2023,
author = {Lin, Chi-Maw and Lin, Long-Wei and Chen, Tseng-Cheng and Ye, Yi-Ling and Chiang, Bor-Luen},
title = {The expression of nicotinic acetylcholine receptor subunits and their associations with local immune cells and prognosis in oral squamous cell carcinoma},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.6482}
}
EUVIMED